Altimmune
ALT
$7.30
Share price
1.53%
Change (1 day)
46.59%
Change (1 year)
Categories
Operating Margin for Altimmune (ALT)
Operating Margin as of May 2024 (TTM): -124,868.00%
According to Altimmune's latest financial reports and stock price the company's current Operating Margin is -124,868.00%. At the end of 2021 the company had an Operating Margin of -2,201.30%.
Operating Margin history for Altimmune from 2006 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -2,201.30% | 230.89% |
| 2020 | -665.26% | 87.57% |
| 2019 | -354.68% | -18.62% |
| 2018 | -435.81% | -9.83% |
| 2017 | -483.33% | 124.42% |
| 2016 | -215.37% | 2575.21% |
| 2015 | -8.05% | -91.95% |
| 2014 | -100.01% | 58.71% |
| 2013 | -63.01% | 262.03% |
| 2012 | -17.41% | -63.98% |
| 2011 | -48.32% | -56.93% |
| 2010 | -112.19% | 19% |
| 2009 | -94.28% | 62.35% |
| 2008 | -58.07% | -48.47% |
| 2007 | -112.70% | -273.05% |
| 2006 | 65.13% | 17.33% |
| 2005 | 55.50% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -36.36% | -99.97% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -8,391.15% | -93.28% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.